Price T Rowe Associates Inc Bausch Health Companies Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $32.3 Million - $40.7 Million	-1,402,927 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $161 Million - $194 Million	-6,447,646 Reduced 82.13%	1,402,927 $39.1 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $70 Million - $83.5 Million	2,553,297 Added 48.2%	7,850,573 $230 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $12.2 Million - $19.7 Million	-572,585 Reduced 9.75%	5,297,276 $168 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $89.9 Million - $124 Million	5,869,861 New	5,869,861 $122 Million

281

278M

21.5M

21.8M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.52B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.